Background Gamma (γ) brain oscillations are dysregulated in Alzheimer’s disease (AD) and can be modulated using transcranial alternating stimulation (tACS). In the present paper, we describe the rationale and design of a study assessing safety, feasibility, clinical and biological efficacy, and predictors of outcome of a home-based intervention consisting of γ-tACS over the precuneus. Methods In a first phase, 60 AD patients will be randomized into two arms: ARM1, 8-week precuneus γ-tACS (frequency: 40 Hz, intensity: 2 mA, duration: 5 60-min sessions/week); and ARM2, 8-week sham tACS (same parameters as the real γ-tACS, with the current being discontinued 5 s after the beginning of the stimulation). In a second phase, all participants will receive 8-week γ-tACS (same parameters as the real γ-tACS in the first phase). The study outcomes will be collected at several timepoints throughout the study duration and include information on safety and feasibility, neuropsychological assessment, blood sampling, electroencephalography, transcranial magnetic stimulation neurotransmitter measures, and magnetic resonance imaging or amyloid positron emission tomography. Results We expect that this intervention is safe and feasible and results in the improvement of cognition, entrainment of gamma oscillations, increased functional connectivity, reduction of pathological burden, and increased cholinergic transmission. Conclusions If our expected results are achieved, home-based interventions using γ-tACS, either alone or in combination with other therapies, may become a reality for treating AD. Trial registration PNRR-POC-2022–12376021.
Frontiers Transcranial alternating current stimulation combined with sound stimulation improves the cognitive function of patients with Alzheimer's disease: A case report and literature review
Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatry
Closing the loop between brain and electrical stimulation: towards precision neuromodulation treatments
Multitracer model for staging cortical amyloid deposition using
Frontiers Tele-supervised home-based transcranial alternating current stimulation (tACS) for Alzheimer's disease: a pilot study
Toward noninvasive brain stimulation 2.0 in Alzheimer's disease. - Abstract - Europe PMC
Immediate neurophysiological effects of transcranial electrical stimulation
Transcranial magnetic stimulation distinguishes Alzheimer disease
Frontiers Tele-supervised home-based transcranial alternating current stimulation (tACS) for Alzheimer's disease: a pilot study
Study design. Legend: RAVL ¼ Rey auditory verbal learning test; tACS ¼
Effects of medial prefrontal transcranial alternating current stimulation on neural activity and connectivity in people with Huntington's disease and neurotypical controls - ScienceDirect
PDF) Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease
In-vivo phase-dependent enhancement and suppression of brain oscillations by transcranial alternating current stimulation (tACS)